EUCTR2004-001662-41-IT进行中（未招募）不适用
A phase 3, randomized, double-blind study of ceftobiprole versus vancomycin in the treatment of complicated skin and skin structure infections
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole MedocarilVersus Vancomycin With Ceftazidime in The Treatment Of Complicated SkinAnd Skin Structure Infections - STRAUSScomplicated skin and skin structure infectionMedDRA version: 5.1Level: HLTClassification code 10040786EUCTR2005-002301-23-LTJohnson & Johnson Pharmaceutical Research & Development, L.L.C.816
进行中（未招募）
不适用
A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole MedocarilVersus Vancomycin With Ceftazidime in The Treatment Of Complicated SkinAnd Skin Structure Infections - STRAUSSEUCTR2005-002301-23-HUJohnson & Johnson Pharmaceutical Research & Development, L.L.C.816
进行中（未招募）
不适用
A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole MedocarilVersus Vancomycin With Ceftazidime in The Treatment Of Complicated SkinAnd Skin Structure Infections - STRAUSScomplicated skin and skin structure infectionMedDRA version: 5.1Level: HLTClassification code 10040786EUCTR2005-002301-23-LVJohnson & Johnson Pharmaceutical Research & Development, L.L.C.816
进行中（未招募）
不适用
A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole MedocarilVersus Vancomycin With Ceftazidime in The Treatment Of Complicated SkinAnd Skin Structure Infections - STRAUSScomplicated skin and skin structure infectionMedDRA version: 5.1Level: HLTClassification code 10040786EUCTR2005-002301-23-EEJohnson & Johnson Pharmaceutical Research & Development, L.L.C.816
进行中（未招募）
1 期
A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole MedocarilVersus Vancomycin With Ceftazidime in The Treatment Of Complicated SkinAnd Skin Structure Infections - STRAUSSEUCTR2005-002301-23-CZJohnson & Johnson Pharmaceutical Research & Development, L.L.C.